Abstract:Background
Congenital bilateral absence of the vas deferens (CBAVD) is a frequent cause of obstructive azoospermia. CBAVD is mainly caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene and is also related to the X‐linked ADGRG2 (adhesion G protein‐coupled receptor G2) gene. Genetic screening and counseling strategies for Chinese CBAVD populations remain controversial because the genetic background of CBAVD in Chinese population is largely unknown.
Objectives
In this study,… Show more
“…The 5T allele polymorphism varies considerably by geographic location and ethnicity, particularly among non-Caucasian populations ( Dork et al, 1997 ). In the current study, the frequency of the 5T allele was the most frequent variant, similar to other reports in Chinese cohorts ( Du et al, 2014 ; Gaikwad et al, 2018 ; Wang et al, 2020 ). No ADGRG2 variants were identified, suggesting ADGRG2 variants may not play a major role in these CAVD populations.…”
Section: Discussionsupporting
confidence: 92%
“…In this study, 29 out of 50 (58%) patients had at least one reportable CFTR variant. These results demonstrated that our CAVD population had a lower percentage than previous reports in which 70%-80% of CBAVD patients carried at least one CFTR mutation (Yu et al, 2012;Wang et al, 2020), which may be due to our small sample size. The variant c.1521_1523delCTT (F508del) is one of the most common variants in northern European CAVD populations, accounting for up to one-third of CAVD patients (Barratt et al, 2017;Bieth et al, 2021), whereas only two (2/50) are carriers in our CAVD patients.…”
Congenital absence of the vas deferens (CAVD) is a major cause of obstructive azoospermia. Mutations of CFTR and ADGRG2 cause the majority of CAVD. Despite this, 10%–20% of CAVD patients remain without a clear genetic diagnosis. Herein, the CFTR and ADGRG2 genes were first sequenced using Sanger sequencing in 50 CAVD patients. Whole-exome sequencing (WES) was used to further identify potential novel genetic causes in CAVD with hypospadias. In total, 29 of 50 CAVD patients carried at least one CFTR mutation, but no ADGRG2 mutation was found. 5T was found to be the most frequent variant in our CAVD populations. Seven CAVD patients with hypospadias were further analyzed using WES. No homozygous or compound heterozygous mutations related to disorders of sex development (DSDs) or male infertility were identified by WES. CAVD with hypospadias presented lower testicular volume (9.71 ± 2.14 ml vs. 14.45 ± 2.93 ml, p < 0.001) and higher FSH level (FSH: 7.28 ± 3.91 IU/L vs. 4.24 ± 1.96 IU/L, p = 0.027) than CAVD without hypospadias. It is worth noting that neither CFTR or ADGRG2 mutation nor homozygous or compound heterozygous gene mutations were identified in seven CAVD cases with hypospadias. However, nine heterozygous or hemizygous mutations were selected as potential pathogenic genes in CAVD with hypospadias. In conclusion, CFTR variants, especially 5T, play a major role in the Chinese CAVD population. CAVD with hypospadias shows relatively lower testicular spermatogenesis, suggesting a different genetic basis or pathogenic factor from cystic fibrosis/CAVD or unilateral renal agenesis/CAVD.
“…The 5T allele polymorphism varies considerably by geographic location and ethnicity, particularly among non-Caucasian populations ( Dork et al, 1997 ). In the current study, the frequency of the 5T allele was the most frequent variant, similar to other reports in Chinese cohorts ( Du et al, 2014 ; Gaikwad et al, 2018 ; Wang et al, 2020 ). No ADGRG2 variants were identified, suggesting ADGRG2 variants may not play a major role in these CAVD populations.…”
Section: Discussionsupporting
confidence: 92%
“…In this study, 29 out of 50 (58%) patients had at least one reportable CFTR variant. These results demonstrated that our CAVD population had a lower percentage than previous reports in which 70%-80% of CBAVD patients carried at least one CFTR mutation (Yu et al, 2012;Wang et al, 2020), which may be due to our small sample size. The variant c.1521_1523delCTT (F508del) is one of the most common variants in northern European CAVD populations, accounting for up to one-third of CAVD patients (Barratt et al, 2017;Bieth et al, 2021), whereas only two (2/50) are carriers in our CAVD patients.…”
Congenital absence of the vas deferens (CAVD) is a major cause of obstructive azoospermia. Mutations of CFTR and ADGRG2 cause the majority of CAVD. Despite this, 10%–20% of CAVD patients remain without a clear genetic diagnosis. Herein, the CFTR and ADGRG2 genes were first sequenced using Sanger sequencing in 50 CAVD patients. Whole-exome sequencing (WES) was used to further identify potential novel genetic causes in CAVD with hypospadias. In total, 29 of 50 CAVD patients carried at least one CFTR mutation, but no ADGRG2 mutation was found. 5T was found to be the most frequent variant in our CAVD populations. Seven CAVD patients with hypospadias were further analyzed using WES. No homozygous or compound heterozygous mutations related to disorders of sex development (DSDs) or male infertility were identified by WES. CAVD with hypospadias presented lower testicular volume (9.71 ± 2.14 ml vs. 14.45 ± 2.93 ml, p < 0.001) and higher FSH level (FSH: 7.28 ± 3.91 IU/L vs. 4.24 ± 1.96 IU/L, p = 0.027) than CAVD without hypospadias. It is worth noting that neither CFTR or ADGRG2 mutation nor homozygous or compound heterozygous gene mutations were identified in seven CAVD cases with hypospadias. However, nine heterozygous or hemizygous mutations were selected as potential pathogenic genes in CAVD with hypospadias. In conclusion, CFTR variants, especially 5T, play a major role in the Chinese CAVD population. CAVD with hypospadias shows relatively lower testicular spermatogenesis, suggesting a different genetic basis or pathogenic factor from cystic fibrosis/CAVD or unilateral renal agenesis/CAVD.
“…Recent research reported that among 263 Chinese patients with CBAVD, 5 (1.9%) patients were detected for copy number variants in the region of the CFTR gene (four of them carried partial deletions and one carried partial duplication of CFTR ), 37 but other studies did not find copy number variations of CFTR in males with CBAVD. 38 , 39 A larger number of samples and more sensitive gene detection methods are essential for further research. Although a specific knock-in mouse model supported our findings, further investigations are needed to clarify the function of CFTR in spermatogenesis in animal models in vivo .…”
Congenital bilateral absence of the vas deferens (CBAVD) is observed in 1%–2% of males presenting with infertility and is clearly associated with cystic fibrosis transmembrane conductance regulator (
CFTR
) mutations.
CFTR
is one of the most well-known genes related to male fertility. The frequency of
CFTR
mutations or impaired
CFTR
expression is increased in men with nonobstructive azoospermia (NOA).
CFTR
mutations are highly polymorphic and have established ethnic specificity. Compared with F508Del in Caucasians, the p.G970D mutation is reported to be the most frequent
CFTR
mutation in Chinese patients with cystic fibrosis. However, whether p.G970D participates in male infertility remains unknown. Herein, a loss-of-function
CFTR
p.G970D missense mutation was identified in a patient with CBAVD and NOA. Subsequent retrospective analysis of 122 Chinese patients with CBAVD showed that the mutation is a common pathogenic mutation (4.1%, 5/122), excluding polymorphic sites. Furthermore, we generated model cell lines derived from mouse testes harboring the homozygous
Cftr
p.G965D mutation equivalent to the
CFTR
variant in patients. The
Cftr
p.G965D mutation may be lethal in spermatogonial stem cells and spermatogonia and affect the proliferation of spermatocytes and Sertoli cells. In spermatocyte GC-2(spd)ts (GC2)
Cftr
p.G965D cells, RNA splicing variants were detected and
CFTR
expression decreased, which may contribute to the phenotypes associated with impaired spermatogenesis. Thus, this study indicated that the
CFTR
p.G970D missense mutation might be a pathogenic mutation for CBAVD in Chinese males and associated with impaired spermatogenesis by affecting the proliferation of germ cells.
“…This finding suggests the presence of a mixed pathology, with both obstructive damage and testicular failure. PESA outcomes justify these; both in terms of activity or vitality were low and abnormality rates were high [25].…”
Section: F I G 2 Fertility Outcomes In Icsi Cycles In Couples With Cbavdmentioning
Background and objective: Congenital bilateral absence of the vas deferens (CBAVD) is not common and fertility outcome is not clear. This study is to report fertility outcomes of infertile male with CBAVD.
Material and methods:Our study cohort comprised CBAVD males who were enrolled from 2005 to 2019. Baseline information was collected including mean age, previous medical history, duration of infertility, sex hormone assays, ejaculate volume/pH, parameters of sperm retrieved by percutaneous epididymal sperm aspiration (PESA), development of seminal vesicle TRUS, follow up fertility outcomes of the patients with Intracytoplasmic sperm injection (ICSI)and compared the impact of varies male factors on fertility outcomes.Results: 172 participants with CBAVD were analyzed. A total of 211 ICSI cycles were performed and the live birth rate was 46.92%. Among 126 live births, 57 (45.24%) were boy and 69 (54.76%) were girl.The neonatal weight and height are 3036.83 ± 672.17 g, 49.43 ± 2.49 cm, respectively. There were no significant differences between successes group of couples and fail group of couples for first ICSI cycles cases in terms of age (P = 0.09), testicle volume (left P = 0.96, right P = 0.41), sex hormones (P > 0.05), ejaculate volume (P = 0.79), ejaculate pH (P = 0.78) or sperm quality parameters from PESA (P > 0.05).
Conclusions:This study indicates that the clinical characteristics of male with CBAVD had no impact on fertility outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.